Clinical Trial Update: A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 study of STRO4 in patients with amyotrophic lateral sclerosis has been terminated. The entry notes sponsor and trial status but does not present resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• STRO4

Snippet

Sponsor: New England Cell Therapeutics, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED